By
Par Pharmaceutical buys Ethics Bio Lab for around $20M

NYSE-listed Par Pharmaceutical, Inc has acquired Ethics Bio Lab Pvt Ltd, a Chennai-based contract research organisation (CRO) in an all cash transaction for around $20 million (Rs 125 crore), VCCircle...

TO READ THE FULL STORY


Leave Your Comment(s)